☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Abbott
Abbott Reports the Initiation of TRANSCEND Trial Assessing Deep Brain Stimulation System to Manage Severe Depression (TRD)
September 5, 2024
Abbott Updates Heart Failure Management by Excluding Aspirin for Patients with the HeartMate 3 Heart Pump
August 23, 2024
Abbott Partners with Medtronic for Continuous Glucose Monitoring System to Improve Diabetes Care
August 9, 2024
The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems
June 11, 2024
Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms
June 7, 2024
Abbott's Esprit BTK System Gains the US FDA’s Approval for Chronic Limb-Threatening Ischemia (CLTI) Below-The-Knee (BTK)
April 30, 2024
Load more...
Back to Home